The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Arcoxia 30 mg film-coated tablets

PCO Manufacturing Ltd.PPA0465/176/004

Main Information

Trade NameArcoxia 30 mg film-coated tablets
Active SubstancesEtoricoxib
Dosage FormFilm-coated tablet
Licence HolderPCO Manufacturing Ltd.
Licence NumberPPA0465/176/004

Group Information

ATC CodeM01AH05 etoricoxib


License statusAuthorised
Licence Issued08/10/2010
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0108-033-003
Interchangeable List DocumentPDF of Interchangeable List
« Back